v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue        
Total revenue $ 44,232 $ 48,863 $ 89,167 $ 97,855
Cost of revenue        
Cost of revenue 15,314 13,875 29,296 26,485
Selling, general, and administrative 32,426 24,223 60,213 50,915
Income (loss) from operations (3,508) 10,765 (342) 20,455
Other income (expense) net :        
Interest expense, net (2,183) (2,852) (4,155) (5,757)
Loss on extinguishment of debt (648)   (648)  
Gain (loss) from change in fair value of earnout liabilities (787) (1,832) 1,362 8,856
Other income (expense), net (6) (6) (11) (24)
Total other income (expense), net (3,624) (4,690) (3,452) 3,075
Income (loss) before provision for income taxes (7,132) 6,075 (3,794) 23,530
Income tax expense 296 2,150 958 3,766
Net income (loss) (7,428) 3,925 (4,752) 19,764
Less: Net income (loss) attributable to noncontrolling interest (865) 740 (466) 2,861
Net income (loss) attributable to biote Corp. stockholders (6,563) 3,185 (4,286) 16,903
Other comprehensive income:        
Foreign currency translation adjustments 2 9 4 5
Other comprehensive income 2 9 4 5
Comprehensive income (loss) $ (7,426) $ 3,934 $ (4,748) $ 19,769
Net income (loss) per common share        
Basic $ (0.23) $ 0.1 $ (0.14) $ 0.54
Diluted $ (0.23) $ 0.1 $ (0.14) $ 0.46
Weighted average common shares outstanding        
Basic 28,626,136 31,625,485 29,630,665 31,556,017
Diluted 28,626,136 31,743,162 29,630,665 36,959,274
Product Revenue        
Revenue        
Total revenue $ 43,381 $ 47,657 $ 87,276 $ 94,682
Cost of revenue        
Cost of revenue 14,301 12,811 27,046 24,465
Service Revenue        
Revenue        
Total revenue 851 1,206 1,891 3,173
Cost of revenue        
Cost of revenue $ 1,013 $ 1,064 $ 2,250 $ 2,020